CA2471083A1 - Benzhydryl derivatives - Google Patents

Benzhydryl derivatives Download PDF

Info

Publication number
CA2471083A1
CA2471083A1 CA002471083A CA2471083A CA2471083A1 CA 2471083 A1 CA2471083 A1 CA 2471083A1 CA 002471083 A CA002471083 A CA 002471083A CA 2471083 A CA2471083 A CA 2471083A CA 2471083 A1 CA2471083 A1 CA 2471083A1
Authority
CA
Canada
Prior art keywords
mass
pyrazino
benzhydryl
nmr
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002471083A
Other languages
English (en)
French (fr)
Inventor
Kazuhiko Take
Chiyoshi Kasahara
Shinji Shigenaga
Yoshiteru Eikyu
Takashi Tojo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2471083A1 publication Critical patent/CA2471083A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002471083A 2001-12-21 2002-12-16 Benzhydryl derivatives Abandoned CA2471083A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR9707A AUPR970701A0 (en) 2001-12-21 2001-12-21 Benzhydryl derivatives
AUPR9707 2001-12-21
PCT/JP2002/013156 WO2003053957A1 (en) 2001-12-21 2002-12-16 Benzhydryl derivatives

Publications (1)

Publication Number Publication Date
CA2471083A1 true CA2471083A1 (en) 2003-07-03

Family

ID=3833320

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002471083A Abandoned CA2471083A1 (en) 2001-12-21 2002-12-16 Benzhydryl derivatives

Country Status (14)

Country Link
US (1) US20050171350A1 (pt)
EP (1) EP1456201A1 (pt)
JP (1) JP2005513132A (pt)
KR (1) KR20040066908A (pt)
CN (1) CN1620451A (pt)
AU (1) AUPR970701A0 (pt)
BR (1) BR0215345A (pt)
CA (1) CA2471083A1 (pt)
IL (1) IL162497A0 (pt)
MX (1) MXPA04006114A (pt)
NO (1) NO20042490L (pt)
RU (1) RU2004122425A (pt)
TW (1) TW200301118A (pt)
WO (1) WO2003053957A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009109001A1 (en) * 2008-03-04 2009-09-11 Adelaide Research & Innovation Pty Ltd Method for preventing and/or treating a disease, condition or state associated with reduced dopaminergic neuron function
US8884034B2 (en) 2009-07-08 2014-11-11 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
CN101798288B (zh) * 2010-03-12 2012-04-11 湖南化工研究院 嘧啶类化合物的提纯方法
CN104592198A (zh) * 2015-01-21 2015-05-06 湖南华腾制药有限公司 一种2-甲基-5-(哌啶-4-基)嘧啶的制备方法
CN109020914A (zh) * 2017-06-12 2018-12-18 上海百灵医药科技有限公司 一种酰基化恶唑烷酮的合成方法
CN109020913A (zh) * 2017-06-12 2018-12-18 上海百灵医药科技有限公司 一种酰基化硫代恶唑烷酮的合成方法
CN114685401A (zh) * 2020-12-28 2022-07-01 江苏天士力帝益药业有限公司 一种二（4-甲基哌嗪-1-基）甲酮的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990008230A (ko) * 1995-05-02 1999-01-25 덜락 노만씨 뉴로키닌 길항제로서의 피페라지노 유도체
US6787543B2 (en) * 2000-06-29 2004-09-07 Fujisawa Pharmaceutical Co., Ltd. Benzhydryl derivatives

Also Published As

Publication number Publication date
KR20040066908A (ko) 2004-07-27
TW200301118A (en) 2003-07-01
MXPA04006114A (es) 2004-11-01
US20050171350A1 (en) 2005-08-04
BR0215345A (pt) 2005-04-05
NO20042490D0 (no) 2004-06-15
EP1456201A1 (en) 2004-09-15
CN1620451A (zh) 2005-05-25
IL162497A0 (en) 2005-11-20
RU2004122425A (ru) 2005-03-27
AUPR970701A0 (en) 2002-01-24
WO2003053957A1 (en) 2003-07-03
NO20042490L (no) 2004-08-18
JP2005513132A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
US11702424B2 (en) Bicyclic-fused heteroaryl or aryl compounds
TWI806832B (zh) 作為異位shp2抑制劑之2,5-雙取代型3-甲基吡嗪及2,5,6-三取代型3-甲基吡嗪
TWI811353B (zh) 作為parp7抑制劑的嗒酮
AU2010286694B2 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists
EP2470021B1 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists
KR102390276B1 (ko) 마크로사이클릭 피리미딘 유도체
EA018953B1 (ru) Ингибиторы пептиддеформилазы
CN113302183A (zh) 环脲
DE69930543T2 (de) Piperazin-derivate
EP4284365A1 (en) Cdk2 inhibitors and methods of using the same
EP0760368A1 (en) Novel pyrimidine derivative
WO2020085234A1 (ja) モルヒナン誘導体
CA2471083A1 (en) Benzhydryl derivatives
US20040220403A1 (en) 1-(2-Methoxybenzyl)-3-benzhydrylpiperazines as tachykinin anatgonists
AU2002361503A1 (en) Benzhydryl derivatives

Legal Events

Date Code Title Description
FZDE Discontinued